Skip to content
Improved Excipient Oral Solution THC 25:CBD 1
come back

Improved Excipient Oral Solution THC 25:CBD 1

≤1% CBD
THC > 25%

SOMAÍ’s improved excipient blend offers increased bioavailability through a high concentration of omega-9 fatty acids. Unlike a triglyceride dominate mixture, the Somai excipient blend is predominantly absorbed into the lymphatic system which avoids first-pass metabolism. This increases the potential bioavailability and reduces the amount of Δ9-Tetrahydrocannabinol (THC) being converted to 11-hydroxy-THC (11-OH-THC) by the liver.

  • Product type
    Dried Flower
    Extracts
    Oils
    Oral Solution
    Oral Sprays
    Soft Gel Caps
    Vapes
  • Apperance
    Colourless to slightly yellowish liquid
  • Cannabionids content
    > 25% THC ≤1% CBD
  • Packaging
    Amber Glass Bottle 30 ml., 500 ml. Glass Type Ill
    White CR&TE screw cap with dosing syringe (PP)
    Magisterial Prep format with TE cap (PP)
  • Storage
    Tightly closed, protected from light, below 15 - 25 °C
  • Stability studies details
    Conducted according to ICH stability guidelines
    Climatic zones: II, IV A, IV B
    Long-term studies: up to 36 months
    Accelerated studies: 6 months